National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$42.00
add to cart

Rights & Permissions

topleft topright

Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security (2005)
Development, Security, and Cooperation (DSC)

Citation Manager

. "6 Reshaping U.S.-Russian Cooperation in the Biological Sciences and Biotechnology." Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
66
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security

ments. In particular, the WHO has for many years encouraged programs related to the control of infectious diseases and has established a number of infectious disease “collaborating centers” in Russia. The WHO will presumably continue to expand these efforts in the future.

EXPANSION OF BILATERAL COOPERATION

In the early 1990s, the U.S. and other Western governments began to support basic research in Russia, including research in the biological sciences. Several U.S. agencies such as the National Science Foundation, the National Institutes of Health, the National Aeronautics and Space Administration, and the Office of Naval Research were increasingly concerned that much of the world-class basic research capability of Russia would be lost because of the sharp decline in funding for science in the country.

Of special concern was the significant loss of talent accompanying the decline in Russian government support for research. As discussed in Chapter 5, this loss of talent has been primarily an internal movement of well-trained specialists away from science careers to the commercial sector in Russia. There has been a less dramatic, but nevertheless important, migration from Russian research laboratories to research centers in other countries.

Starting in 1994, the U.S. government initiated several nonproliferation programs that involved cooperative biological research activities. The programs were intended to help ensure that Russian expertise in biology and related fields relevant to weapons would not be transferred deliberately or inadvertently to countries or groups with intentions hostile to U.S. interests. More recently, related nonproliferation programs initiated by the U.S. government have improved safety and security procedures at Russian facilities where strains of dangerous pathogens are stored. These programs also have upgraded facilities for breeding research-quality rodents and for toxicological experiments with rodents and other small animals. Now refurbishing research and manufacturing facilities is underway so that they meet requirements for Good Laboratory Practices and Good Manufacturing Practices as called for by recently promulgated Russian regulations. In addition, biotechnology and the life sciences are clearly a priority area of interest to the International Science and Technology Center in Moscow (ISTC), an international program, which is sponsored by the U.S. and several other governments (see Figure 6.1).

The rapid spread of tuberculosis and HIV/AIDS in Russia has attracted considerable attention from the U.S. government, resulting in funding provided primarily by the U.S. Agency for International Development, which has a health, and not a nonproliferation, mandate (see Box 6.1). To address a number of other diseases as well, six U.S. departments have sizable programs to redirect former weapons expertise to public health, agriculture, and environmental problems within the framework of nonproliferation. The severe acute respiratory syndrome

Page
66
Front Matter (R1-R10)
Summary (1-9)
Introduction (10-20)
1 The Vision for Russia’s Future (21-26)
2 Pillar One: Improving Surveillance and Response (27-35)
3 Pillar Two: Meeting Pathogen Research Challenges (36-46)
4 Pillar Three: The Promise of Biotechnology (47-58)
5 Pillar Four: The Human Resource Base (59-64)
6 Reshaping U.S.-Russian Cooperation in the Biological Sciences and Biotechnology (65-75)
Epilogue (76-78)
Appendix A Committee Biographies (79-85)
Appendix B Organizations Consulted During the Study (86-88)
Appendix C Decision of the Board of the Ministry of Health of the Russian Federation: Tasks for the Periods 2001-2005 and 2006-2010 from Protocol #6 (89-92)
Appendix D Main Goals and Objectives in Combating Infectious Diseases in the Russian Federation (93-95)
Appendix E Regulations on the Federal Service for the Supervision in the Sphere of Health and Social Development (96-103)
Appendix F Recent Reports by the National Academies on Global Health Concerns (104-105)
Appendix E Regulations Regarding the Federal Service for the Supervision in the Sphere of Health and Social Development (106-107)
Appendix H Highest Priority Measures for Creating a System to Counter Biological Terrorism (108-112)
Appendix I National Immunization Calendar of the Russian Federation (113-114)
Appendix J Selected Russian Research and Related Institutions with Activities Relevant to Infectious Diseases, Diagnostics, Treatment, Prevention, and Control (115-119)
Appendix K Scientific and Methodological Research Results Highlighted by the Russian Ministry of Health and Social Development (120-124)
Appendix L List of Research Projects Proposed in Open Competitions Organized in 2003 (125-126)
Appendix M Test Systems and Other Products Being Developed in Russian Laboratories (127-130)
Appendix N RosAgroBioProm Organizational Structure (131-131)
Appendix O Activities of Russian Research Institutes in Developing Vaccines for Human Use (132-132)
Appendix P Regulation of the Russian Government on Licensing Activities Connected with the Use of Infectious Disease Antidotes, No. 731 (133-136)
Appendix Q Bioengagement Programs Financed by the United States Government (137-142)
Appendix R International Programs and Projects of Special Significance to the Ministry of Health and Social Development (143-144)
Selected Bibliography (145-146)